8-K: Profusa Secures $100M Equity Line for Bitcoin Buys
Equity Financing Agreement
Profusa, Inc. has entered into a Securities Purchase Agreement with Ascent Partners Fund LLC, allowing the company to sell up to $100 million in common stock, primarily for Bitcoin purchases.
Summary
- Profusa, Inc. (the Company) has entered into a Securities Purchase Agreement (SPA) with Ascent Partners Fund LLC (the Purchaser) to sell up to $100,000,000 of its common stock (Purchased Securities).
- The purchase price per share will be 97% of the lowest volume-weighted average price (VWAP) of the Company's common stock during a 10-trading day valuation period, subject to a floor price.
- Each individual purchase (closing) is limited to the lower of $5,000,000 or 100% of the average daily traded value of the common stock for the five trading days immediately preceding such closing.
- The aggregate number of shares issued under the SPA is capped at 19.9% of the Company's outstanding common stock, unless stockholder approval is obtained or as otherwise permitted by Nasdaq rules.
- The Purchaser's beneficial ownership of the Company's common stock is limited to 9.99% of the outstanding shares immediately after giving effect to any issuance.
- As consideration for Ascent's commitment, Profusa issued warrants (Commitment Warrants) to purchase 900,000 shares of common stock at an exercise price of $0.01 per share.
- The number of shares underlying the Commitment Warrants will be automatically reduced by 50% to 450,000 if no Purchased Securities are issued to the Holder on or before the 100th day from the SPA date.
- Proceeds from the sale of the Purchased Securities are to be used exclusively for the purchase of Bitcoin (which may be used for repayment of indebtedness), provided the Company's cash balance on any closing date exceeds $5,000,000.
- If the cash balance is less than $5,000,000, proceeds must first be used to bring the cash balance to that amount, with the remainder used to purchase Bitcoin.
- The Company is prohibited from using proceeds for executive compensation, distributions, or repayment of indebtedness to security holders.
- A Registration Rights Agreement was also executed, requiring the Company to file an initial registration statement for resale of the Registrable Securities within 10 calendar days and use best efforts to cause it to be declared effective within 30 calendar days.
- The SPA will terminate on the earlier of July 27, 2028, the date the Purchaser has purchased the Maximum Aggregate Purchase Price, or upon notice of termination by either party.
Sentiment
Score: 3
Explanation: While the company secured a significant financing facility, the mandated use of proceeds primarily for Bitcoin purchases introduces substantial speculative risk and volatility, which is highly unusual for a public company's core operations. This, combined with the potential for significant shareholder dilution and sales at a discount to market price, outweighs the benefit of securing capital, leading to a negative sentiment.
Positives
- Secures access to up to $100,000,000 in capital through an equity line, providing a flexible funding source for the Company.
- The Company retains discretion on when to issue and sell shares, allowing flexibility in managing capital raises.
- The agreement includes standard indemnification provisions protecting the Purchaser, which is a common and expected term in such financing arrangements.
- The Company has taken necessary actions to render anti-takeover provisions inapplicable, facilitating the transaction and the Purchaser's ability to acquire shares.
Negatives
- Potential for significant shareholder dilution due to the issuance of up to $100,000,000 in common stock, especially if the stock price declines.
- The purchase price is set at 97% of the lowest volume-weighted average price (VWAP) during a 10-day valuation period, which could result in sales at a discount to the prevailing market price.
- The use of proceeds is restricted primarily to Bitcoin purchases, introducing cryptocurrency market volatility risk and potentially limiting the Company's flexibility for other operational needs if the cash balance is below $5,000,000.
- The commitment warrant shares are reduced by 50% if no purchased securities are bought within 100 days, indicating a potential penalty for not utilizing the facility.
- Restrictions on the Company from entering into certain other equity line or at-the-market transactions without the Purchaser's consent limit future financing options.
- The Company is obligated to pay liquidated damages if it fails to meet certain registration requirements or if the registration statement ceases to be effective.
Risks
- Dilution Risk: The issuance of up to $100,000,000 in common stock may result in substantial dilution for existing shareholders, particularly if the stock price decreases.
- Market Price Volatility: The purchase price is tied to the lowest VWAP during a valuation period, meaning sales could occur at a discount to the market price, especially in volatile trading conditions.
- Bitcoin Price Volatility: Proceeds are primarily for Bitcoin purchases, exposing the Company to the inherent volatility and risks associated with cryptocurrency markets, which are highly speculative.
- Regulatory Compliance Risk: Failure to comply with SEC filing requirements (e.g., timely registration statement effectiveness) or exchange listing rules could result in penalties or suspension of trading.
- Operational Restrictions: Covenants restrict the Company from certain financing activities (e.g., other equity lines, at-the-market offerings) without the Purchaser's consent, potentially limiting strategic flexibility.
- Shareholder Approval Risk: If the issuance exceeds 19.9% of outstanding common stock, shareholder approval is required, which introduces uncertainty and potential delays in capital raising.
- Liquidity Risk: If the Company fails to timely deliver shares, the Purchaser has remedies including rescinding the advance notice or requiring the Company to pay cover costs, which could impact the Company's liquidity.
Future Outlook
Profusa, Inc. has secured a flexible equity financing facility of up to $100 million, which it intends to primarily use for Bitcoin purchases, signaling a strategic move into digital assets. The company is committed to maintaining SEC compliance and listing standards to facilitate future capital raises and ensure the liquidity of the issued securities.
Management Comments
- "The Company acknowledges that the issuance of the Transaction Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions."
- "The Company further acknowledges that its obligations under the Transaction Documents, including its obligation to issue the Transaction Securities pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against the Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company."
Industry Context
This financing agreement, often referred to as an 'equity line of credit' or 'standby equity purchase agreement,' is a common mechanism for smaller public companies to access capital on an 'as-needed' basis. The specific allocation of proceeds towards Bitcoin purchases is a notable deviation from typical operational or R&D funding, indicating a strategic pivot or diversification into digital assets, which is an emerging trend among some companies, though it introduces significant market volatility risks not typically associated with traditional corporate finance.
Comparison to Industry Standards
- The equity line structure, allowing the company to draw funds over time at a discount to VWAP, is a standard financing tool for companies seeking flexible capital without a large upfront commitment.
- The 19.9% exchange cap (e.g., Nasdaq rule) is a common limitation in such agreements to avoid requiring immediate shareholder approval, aligning with standard market practices for smaller capital raises.
- The 9.99% beneficial ownership limitation for the investor is also standard to prevent triggering certain reporting requirements or control provisions.
- The use of proceeds for Bitcoin purchases is highly unconventional for a company like Profusa (which based on its name and address, might be a medical device or biotech company). This deviates significantly from industry standards for capital allocation in most sectors, which typically prioritize R&D, operational expenses, or debt reduction. This specific use of funds is more akin to a speculative investment strategy rather than traditional corporate financing.
- The inclusion of a commitment warrant and registration rights agreement are standard components of such equity line facilities, providing incentives and liquidity pathways for the investor.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Anti-Takeover Provisions | The Company and its Board of Directors have taken all necessary action to render inapplicable any control share acquisition, business combination, poison pill, or similar anti-takeover provisions that could apply as a result of the transaction. | July 28, 2025 | Facilitates the equity financing by removing potential obstacles related to shareholder rights plans or other anti-takeover measures, ensuring the Purchaser's ability to acquire shares without triggering adverse provisions. |
| Shareholder Approval Requirement | Stockholder approval is required if the aggregate number of shares issued under the Purchase Agreement exceeds the exchange cap (generally 19.9% of outstanding common stock). The Company commits to holding a special meeting or obtaining written consent for this purpose. | July 28, 2025 | Introduces a potential future governance event that could impact the pace and scale of capital raising if the Company needs to issue shares beyond the 19.9% threshold, requiring shareholder consent. |
Stakeholder Impact
- Shareholders: Potential for significant dilution due to new share issuances. The use of proceeds for Bitcoin introduces speculative risk to the company's asset base, which could negatively impact shareholder value.
- Creditors: Proceeds may be used for repayment of indebtedness (via Bitcoin), which could be positive for creditors, but the primary use for Bitcoin introduces risk to the company's financial health.
- Management/Employees: The prohibition on using proceeds for executive compensation or distributions suggests no direct benefit to management/employees from this specific capital raise, though securing capital generally supports ongoing operations.
Next Steps
- Company to file an initial registration statement with the SEC covering the resale of Registrable Securities no later than 10 calendar days after the Registration Rights Agreement date (July 28, 2025).
- Company to use best efforts to cause the registration statement to be declared effective within 30 calendar days following the filing date (or 5 trading days if no SEC review).
- Company to maintain the effectiveness of the registration statement until all Registrable Securities have been sold or are eligible for resale without restriction under Rule 144.
- Company may deliver advance notices to the Purchaser to request purchases of common stock, with closings occurring on a trading day following a 10-day valuation period.
- If required, the Company will hold a special meeting of stockholders to obtain approval for share issuances exceeding the exchange cap (19.9%).
Key Dates
| Date | Description |
|---|---|
| 2025-07-20 | Date of Term Sheet between Profusa, Inc. and Ascent Partners Fund LLC, pursuant to which the Commitment Warrants were issued. |
| 2025-07-25 | Date used for calculating the Floor Price (Official Closing Price on this date). |
| 2025-07-27 | Date of signing for Registration Rights Agreement by Profusa, Inc. and Ascent Partners Fund LLC. |
| 2025-07-28 | Date of Report (earliest event reported), date of Securities Purchase Agreement, and Issue Date of Commitment Warrant. |
| 2028-07-27 | Termination date of the Securities Purchase Agreement. |
| 2030-07-28 | Expiration Date of the Commitment Warrant (fifth anniversary of its Issue Date). |
Recommendation
sellWhile the company has secured a significant capital facility, the explicit and primary use of proceeds for Bitcoin purchases introduces an extremely high level of speculative risk and volatility to the company's financial strategy. This deviates sharply from traditional corporate capital allocation and suggests a speculative rather than a fundamental business focus. Combined with the inherent dilution from an equity line and the potential for sales at a discount to market price, this transaction significantly increases the risk profile for investors. The speculative nature of Bitcoin investment, coupled with the potential for substantial dilution, makes this a high-risk proposition, warranting a 'sell' recommendation for risk-averse investors or those seeking stable growth.
Keywords
Profusa, Ascent Partners Fund, Equity Line, Securities Purchase Agreement, Warrant, Common Stock, Capital Raise, Dilution, SEC Filing, 8-K, Financing, Bitcoin Investment, Registration Rights, Corporate Finance, Public Company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.